Demucin
Indication
Secretolytic therapy in acute and chronic bronchopulmonary diseases associated with abnormal mucus secretion and impaired mucus transport.
Composition
Each ml contains:
Bromhexine hydrochloride 2 mg
Package
Dosage Forms
ATC Classification
Warning
There have been reports of severe skin reactions such as erythema multiforme, Stevens-Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN), and acute generalized exanthematous pustulosis (AGEP) associated with the administration of bromhexine hydrochloride. Mostly these could be explained by the patient’s underlying disease and/or concomitant medication. In addition, during the early phase of Stevens-Johnson syndrome or TEN, a patient can first experience nonspecific influenza-like prodomes like e.g. fever, aching body, rhinitis, cough, and sore throat. Misled by these nonspecific influenza-like prodomes it is possible that a symptomatic treatment is started with a cough and cold medication.
If symptoms or signs of a progressive skin rash (sometimes associated with blisters or mucosal lesions) are present, bromhexine hydrochloride treatment should be discontinued immediately and medical advice should be sought.
Dosage
In severe cases as well as before and after surgical intervention, 1 ampoule IV (duration of injection 2–3 minutes) 2–3 times daily.
The injection can also be given as an IV infusion.








